Related references
Note: Only part of the references are listed.Growth-Differentiation Factor-15 and Major Cardiac Events
Jeng-Feng Lin et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2014)
Global Perspective on Acute Coronary Syndrome A Burden on the Young and Poor
Rajesh Vedanthan et al.
CIRCULATION RESEARCH (2014)
Growth differentiation factor-15 in Takotsubo cardiomyopathy: Diagnostic and prognostic levalue
T. Stiermaier et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: An Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy
Peter Damman et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
Pawel Kawalec et al.
CLINICAL RHEUMATOLOGY (2013)
Giant Pulmonary Artery Aneurysm With Dissection in a Case of Marfan Syndrome
Purendra K. Pati et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Can You Predict What Happens When EuroSCORE Weds Biomarker?
Richard A. Lange
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Gender Impact on Prognosis of Acute Coronary Syndrome Patients Treated With Drug-Eluting Stents
Farzin Fath-Ordoubadi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Relation of Growth-Differentiation Factor 15 to Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction
Alberto Dominguez-Rodriguez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome Observations From PROVE IT-TIMI 22
Marc P. Bonaca et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance
Ingo Eitel et al.
HEART (2011)
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
Tibor Kempf et al.
NATURE MEDICINE (2011)
Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure Relation to Disease Severity and Prognosis in the Valsartan Heart Failure Trial
Inder S. Anand et al.
CIRCULATION (2010)
Growth- Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non-ST-Segment-Elevation Acute Coronary Syndrome
Kai M. Eggers et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified
Michael D. Coory
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Divergent Molecular Mechanisms Underlying the Pleiotropic Functions of Macrophage Inhibitory Cytokine-1 in Cancer
Murielle Mimeault et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure
Lutz Frankenstein et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease Results From the AtheroGene Study
Tibor Kempf et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
The Report Card on Growth Differentiation Factor 15 Consistent Marks But Not Yet Ready for Promotion
Anand Rohatgi et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
Tibor Kempf et al.
EUROPEAN HEART JOURNAL (2007)
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
T Kempf et al.
CIRCULATION RESEARCH (2006)
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study
DA Brown et al.
LANCET (2002)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
